These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 33350878)

  • 21. Time-Related Changes in Yield and Harms of Screening Breast Magnetic Resonance Imaging.
    Pederson HJ; O'Rourke C; Lyons J; Patrick RJ; Crowe JP; Grobmyer SR
    Clin Breast Cancer; 2015 Oct; 15(5):348-52. PubMed ID: 25749071
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The positive predictive value of the breast imaging reporting and data system (BI-RADS) as a method of quality assessment in breast imaging in a hospital population.
    Zonderland HM; Pope TL; Nieborg AJ
    Eur Radiol; 2004 Oct; 14(10):1743-50. PubMed ID: 15243715
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biennial screening mammography: How many women ask for more? Estimate of the interval mammogram rate in an organised population-based screening programme.
    Carbonaro LA; Rizzo SS; Schiaffino S; Pisani Mainini A; Berger N; Trimboli RM; Sardanelli F
    Radiol Med; 2021 Feb; 126(2):200-205. PubMed ID: 32577906
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of Resource Utilization and Clinical Outcomes Following Screening with Digital Breast Tomosynthesis Versus Digital Mammography: Findings From a Learning Health System.
    Alsheik NH; Dabbous F; Pohlman SK; Troeger KM; Gliklich RE; Donadio GM; Su Z; Menon V; Conant EF
    Acad Radiol; 2019 May; 26(5):597-605. PubMed ID: 30057195
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Trends in mammography 1991-96 and the impact of nationwide screening in The Netherlands.
    van Leiden HA; van Gessel-Dabekaussen AA; van der Maas PJ; de Koning HJ
    J Med Screen; 1999; 6(2):94-8. PubMed ID: 10444728
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Examining the Association Between the COVID-19 Pandemic and the Rate of Diagnostic Tests for Breast, Cervical, and Colorectal Cancer in Manitoba, Canada.
    Decker KM; Musto G; Bucher O; Czaykowski P; Hebbard P; Kim JO; Singh H; Thiessen M; Feely A; Galloway K; Lambert P
    Technol Cancer Res Treat; 2024; 23():15330338241263616. PubMed ID: 39053019
    [No Abstract]   [Full Text] [Related]  

  • 27. Are there racial/ethnic disparities among women younger than 40 undergoing mammography?
    Kapp JM; Walker R; Haneuse S; Buist DS; Yankaskas BC
    Breast Cancer Res Treat; 2010 Nov; 124(1):213-22. PubMed ID: 20204501
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lesion and patient characteristics associated with malignancy after a probably benign finding on community practice mammography.
    Lehman CD; Rutter CM; Eby PR; White E; Buist DS; Taplin SH
    AJR Am J Roentgenol; 2008 Feb; 190(2):511-5. PubMed ID: 18212240
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Chiraiya project: a retrospective analysis of breast cancer detection gaps addressed via mobile mammography in Jammu Province, India.
    Gupta G; Jamwal N; Gupta R
    BMC Public Health; 2024 Aug; 24(1):2087. PubMed ID: 39090665
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pattern of breast cancer presentation during the COVID-19 pandemic: results from a cohort study in the UK.
    Borsky K; Shah K; Cunnick G; Tsang-Wright F
    Future Oncol; 2022 Feb; 18(4):437-443. PubMed ID: 35018787
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnostic interval for non-screening patients undergoing mammography during the COVID-19 pandemic.
    Crivellaro P; Tafur M; George R; Muradali D
    Eur Radiol; 2022 Jan; 32(1):613-620. PubMed ID: 34143286
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Breast imaging and cancer diagnosis during the COVID-19 pandemic: recommendations from the Italian College of Breast Radiologists by SIRM.
    Pediconi F; Galati F; Bernardi D; Belli P; Brancato B; Calabrese M; Camera L; Carbonaro LA; Caumo F; Clauser P; Girardi V; Iacconi C; Martincich L; Panizza P; Petrillo A; Schiaffino S; Tagliafico A; Trimboli RM; Zuiani C; Sardanelli F; Montemezzi S
    Radiol Med; 2020 Oct; 125(10):926-930. PubMed ID: 32661780
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Breast Biopsy Intensity and Findings Following Breast Cancer Screening in Women With and Without a Personal History of Breast Cancer.
    Buist DSM; Abraham L; Lee CI; Lee JM; Lehman C; O'Meara ES; Stout NK; Henderson LM; Hill D; Wernli KJ; Haas JS; Tosteson ANA; Kerlikowske K; Onega T;
    JAMA Intern Med; 2018 Apr; 178(4):458-468. PubMed ID: 29435556
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mammographic assessment of a geographically defined population at a mastology referral hospital in São Paulo Brazil.
    Caetano S; Junior JM; Finguerman F; Goldman SM; Szejnfeld J
    PLoS One; 2013; 8(9):e74270. PubMed ID: 24066130
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The National Breast and Cervical Cancer Early Detection Program: report on the first 4 years of mammography provided to medically underserved women.
    May DS; Lee NC; Nadel MR; Henson RM; Miller DS
    AJR Am J Roentgenol; 1998 Jan; 170(1):97-104. PubMed ID: 9423608
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Repercussions of the COVID-19 pandemic on breast cancer actions in a Brazilian state.
    Dos Santos Dias PD; de Santana ME; de Azevedo Lima VL
    Invest Educ Enferm; 2024 Jun; 42(2):. PubMed ID: 39083831
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluating Trends in Screening Mammography Volumes at a Tertiary Academic Institution During the COVID-19 Pandemic.
    Ambinder EB; Carson KA; Nguyen DL; Cha E; Peshtani A; Myers KS; Oluyemi ET
    J Am Coll Radiol; 2024 Jul; 21(7):1067-1071. PubMed ID: 38378103
    [No Abstract]   [Full Text] [Related]  

  • 38. Patterns of Breast Imaging Use Among Women with a Personal History of Breast Cancer.
    Henderson LM; Ichikawa L; Buist DSM; Lee JM; Bush M; Johnson D; Onega T; Nekhlyudov L; Kerlikowske K; Miglioretti DL; Sprague BL; Wernli KJ
    J Gen Intern Med; 2019 Oct; 34(10):2098-2106. PubMed ID: 31410813
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of the Utility of Screening Mammography for High-Risk Women Undergoing Screening Breast MR Imaging.
    Lo G; Scaranelo AM; Aboras H; Ghai S; Kulkarni S; Fleming R; Bukhanov K; Crystal P
    Radiology; 2017 Oct; 285(1):36-43. PubMed ID: 28586291
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of Screening Mammography to Detect Occult Malignancy in Autologous Breast Reconstructions: A 15-year Experience.
    Noroozian M; Carlson LW; Savage JL; Jeffries DO; Joe AI; Neal CH; Patterson SK; Hadjiiski LM; Helvie MA
    Radiology; 2018 Oct; 289(1):39-48. PubMed ID: 30129903
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.